These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 23026787)
1. Vasopressors for hypotensive shock. Lampard JG; Lang E Ann Emerg Med; 2013 Mar; 61(3):351-2. PubMed ID: 23026787 [No Abstract] [Full Text] [Related]
2. [Basic principles of the therapy of shock]. Schröder R Minerva Med; 1972 Dec; 63(93):5243-6. PubMed ID: 4646406 [No Abstract] [Full Text] [Related]
3. Comparison of dopamine and norepinephrine in shock. Romero CM N Engl J Med; 2010 Jun; 362(24):2328; author reply 2330-1. PubMed ID: 20554990 [No Abstract] [Full Text] [Related]
4. Comparison of dopamine and norepinephrine in shock. Lee J N Engl J Med; 2010 Jun; 362(24):2328-9; author reply 2330-1. PubMed ID: 20560159 [No Abstract] [Full Text] [Related]
5. Comparison of dopamine and norepinephrine in shock. De Santis V; Nencini C; Tritapepe L N Engl J Med; 2010 Jun; 362(24):2329; author reply 2330-1. PubMed ID: 20560160 [No Abstract] [Full Text] [Related]
6. Norepinephrine vs. dopamine: new recommendations for initial vasopressor selection in septic shock. Bartel B S D Med; 2014 May; 67(5):200-1. PubMed ID: 24851468 [No Abstract] [Full Text] [Related]
7. Vasopressin in catecholamine-resistant septic and cardiogenic shock in very-low-birthweight infants. Meyer S; Löffler G; Polcher T; Gottschling S; Gortner L Acta Paediatr; 2006 Oct; 95(10):1309-12. PubMed ID: 16982509 [TBL] [Abstract][Full Text] [Related]
9. Vasoactive drug support in septic shock. Dries DJ Shock; 2006 Nov; 26(5):529-30. PubMed ID: 17047528 [No Abstract] [Full Text] [Related]
10. Dopamine versus norepinephrine in the treatment of shock. Nathan Coxford R; Lang E; Dowling S CJEM; 2011 Nov; 13(6):395-7. PubMed ID: 22436478 [TBL] [Abstract][Full Text] [Related]
11. [The use of sympathomimetics and sympatholytics in shock]. Torsti P Duodecim; 1971; 87(4):297-304. PubMed ID: 5547048 [No Abstract] [Full Text] [Related]
12. Norepinephrine administration in septic shock: how much is enough? De Backer D; Vincent JL Crit Care Med; 2002 Jun; 30(6):1398-9. PubMed ID: 12072710 [No Abstract] [Full Text] [Related]
13. Vasopressor dosing in septic shock. Alaniz C; Pollard S Crit Care Med; 2013 Dec; 41(12):e483-4. PubMed ID: 24275412 [No Abstract] [Full Text] [Related]
14. Cardiogenic shock and its current treatment. Willerson JT Tex Med; 1975 Apr; 71(4):49-59. PubMed ID: 1135757 [No Abstract] [Full Text] [Related]
15. Vasopressor weaning in patients with septic shock. Arellano DL; Hanneman SK Crit Care Nurs Clin North Am; 2014 Sep; 26(3):413-25. PubMed ID: 25169693 [TBL] [Abstract][Full Text] [Related]
16. [Experimental and clinical experience in the use of vasoconstrictor and vasodilator agents in the intensive care and emergencies]. Grabarić B; Pantelić D Vojnosanit Pregl; 1973; 30(5):452-4. PubMed ID: 4772855 [No Abstract] [Full Text] [Related]
17. Vasopressor use in adult patients. Ferguson-Myrthil N Cardiol Rev; 2012; 20(3):153-8. PubMed ID: 22318007 [TBL] [Abstract][Full Text] [Related]
18. The authors reply. Annane D; Dellinger RP Crit Care Med; 2013 Dec; 41(12):e484. PubMed ID: 24275413 [No Abstract] [Full Text] [Related]
19. [Problems in the treatment of cardiogenic shock]. Heublein B; Parsi RA Dtsch Gesundheitsw; 1970 Apr; 25(16):732-7. PubMed ID: 4320726 [No Abstract] [Full Text] [Related]
20. Essential lessons in cardiogenic shock: epinephrine versus norepinephrine/dobutamine. Krenn L; Delle Karth G Crit Care Med; 2011 Mar; 39(3):583-4. PubMed ID: 21330855 [No Abstract] [Full Text] [Related] [Next] [New Search]